5'-AMP-activated protein kinase alpha-1 beta-2 gamma-1 heterotrimer (AMPK α1β2γ1) (AMPK α1β2γ1)

The 5'-AMP-activated protein kinase (AMPK) α1β2γ1 heterotrimer is a critical metabolic sensor that maintains cellular energy balance by monitoring the ratio of AMP/ADP to ATP (Hardie et al., 2012). This specific heterotrimeric complex comprises the catalytic α1 subunit (PRKAA1), the scaffolding β2 subunit (PRKAB2), and the regulatory γ1 subunit (PRKAG1) (UniProt P54646, O43741, P54619). Upon activation by low energy status or pharmacological agents, the complex phosphorylates key downstream targets like Acetyl-CoA Carboxylase (ACC) to inhibit lipid synthesis and promote fatty acid oxidation (Myers et al., 2017). The α1β2γ1 isoform is widely distributed but plays a significant role in tissues like the liver and vascular endothelium, where it regulates glucose uptake and inflammatory responses. Therapeutic targeting of this complex is primarily focused on treating type 2 diabetes, non-alcoholic steatohepatitis (NASH), and cardiovascular disorders by mimicking a state of energy deficit (Poxel Pharma, 2023). However, drug development faces challenges in achieving isoform specificity to avoid potential adverse effects such as cardiac hypertrophy, which has been linked to chronic pan-AMPK activation in some models (Hardie, 2014).

Other names

PRKAA1-PRKAB2-PRKAG1 complexAMPK alpha1 beta2 gamma1Adenosine monophosphate-activated protein kinase alpha-1 beta-2 gamma-1

Allosteric activation by AMP/ADP or small-molecule activators at the ADaM site; promotion of Thr172 phosphorylation by upstream kinases (LKB1, CaMKK2); inhibition of ATP-consuming anabolic pathways and activation of ATP-producing catabolic pathways (Hardie et al., 2012; Myers et al., 2017).